84 related articles for article (PubMed ID: 12168903)
1. Clinical significance of AXL kinase family in gastric cancer.
Wu CW; Li AF; Chi CW; Lai CH; Huang CL; Lo SS; Lui WY; Lin WC
Anticancer Res; 2002; 22(2B):1071-8. PubMed ID: 12168903
[TBL] [Abstract][Full Text] [Related]
2. The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target.
Koorstra JB; Karikari CA; Feldmann G; Bisht S; Rojas PL; Offerhaus GJ; Alvarez H; Maitra A
Cancer Biol Ther; 2009 Apr; 8(7):618-26. PubMed ID: 19252414
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
Qin Y; Zhang J; Wu L; Zhang D; Fu L; Xue X
Int J Clin Pharmacol Ther; 2018 Mar; 56(3):120-129. PubMed ID: 29319497
[TBL] [Abstract][Full Text] [Related]
4. Surgical-Orthodontic Correction of Skeletal Class III Malocclusion with Vertical Maxillary Excess.
Lim SM
J Clin Orthod; 2016 Dec; 50(12):754-766. PubMed ID: 28245437
[No Abstract] [Full Text] [Related]
5. Why sneezing is good for you: Allergies may have emerged to protect us from environmental toxins.
Moyer MW
Sci Am; 2012 Jul; 307(1):20. PubMed ID: 22779261
[No Abstract] [Full Text] [Related]
6. Expression of axl in lung adenocarcinoma and correlation with tumor progression.
Shieh YS; Lai CY; Kao YR; Shiah SG; Chu YW; Lee HS; Wu CW
Neoplasia; 2005 Dec; 7(12):1058-64. PubMed ID: 16354588
[TBL] [Abstract][Full Text] [Related]
7. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
Sawabu T; Seno H; Kawashima T; Fukuda A; Uenoyama Y; Kawada M; Kanda N; Sekikawa A; Fukui H; Yanagita M; Yoshibayashi H; Satoh S; Sakai Y; Nakano T; Chiba T
Mol Carcinog; 2007 Feb; 46(2):155-64. PubMed ID: 17186543
[TBL] [Abstract][Full Text] [Related]
8. AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective.
Myers SH; Brunton VG; Unciti-Broceta A
J Med Chem; 2016 Apr; 59(8):3593-608. PubMed ID: 26555154
[TBL] [Abstract][Full Text] [Related]
9. Decitabine: a promising epi-immunotherapeutic agent in solid tumors.
Li X; Mei Q; Nie J; Fu X; Han W
Expert Rev Clin Immunol; 2015 Mar; 11(3):363-75. PubMed ID: 25578329
[TBL] [Abstract][Full Text] [Related]
10. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival.
van Ginkel PR; Gee RL; Shearer RL; Subramanian L; Walker TM; Albert DM; Meisner LF; Varnum BC; Polans AS
Cancer Res; 2004 Jan; 64(1):128-34. PubMed ID: 14729616
[TBL] [Abstract][Full Text] [Related]
11. Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.
Hirai S; Yamada T; Katayama Y; Ishida M; Kawachi H; Matsui Y; Nakamura R; Morimoto K; Horinaka M; Sakai T; Sekido Y; Tokuda S; Takayama K
Mol Cancer Ther; 2024 Feb; 23(2):212-222. PubMed ID: 37802502
[TBL] [Abstract][Full Text] [Related]
12. Zinc Finger Proteins in the War on Gastric Cancer: Molecular Mechanism and Clinical Potential.
Liu S; Liu X; Lin X; Chen H
Cells; 2023 May; 12(9):. PubMed ID: 37174714
[TBL] [Abstract][Full Text] [Related]
13. Targeting MERTK and AXL in
Yan D; Earp HS; DeRyckere D; Graham DK
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830794
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of TAM receptors Tyro3, Axl, and MerTK: Role in tumors and the tumor immune microenvironment.
Wang KH; Ding DC
Tzu Chi Med J; 2021; 33(3):250-256. PubMed ID: 34386362
[TBL] [Abstract][Full Text] [Related]
15. Implications of the Receptor Tyrosine Kinase Axl in Gastric Cancer Progression.
He L; Lei Y; Hou J; Wu J; Lv G
Onco Targets Ther; 2020; 13():5901-5911. PubMed ID: 32606800
[TBL] [Abstract][Full Text] [Related]
16. Rational Drug Design of Axl Tyrosine Kinase Type I Inhibitors as Promising Candidates Against Cancer.
Sarukhanyan E; Shityakov S; Dandekar T
Front Chem; 2019; 7():920. PubMed ID: 32117858
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer.
Song X; Akasaka H; Wang H; Abbasgholizadeh R; Shin JH; Zang F; Chen J; Logsdon CD; Maitra A; Bean AJ; Wang H
J Biol Chem; 2020 Feb; 295(8):2348-2358. PubMed ID: 31959629
[TBL] [Abstract][Full Text] [Related]
18. Ursolic Acid Inhibits Epithelial-Mesenchymal Transition through the Axl/NF-
Li J; Dai C; Shen L
Evid Based Complement Alternat Med; 2019; 2019():2474805. PubMed ID: 31281396
[TBL] [Abstract][Full Text] [Related]
19. Engineered AXL
Duan Y; Hu B; Qiao C; Luo L; Li X; Wang J; Liu H; Zhou T; Shen B; Lv M; Feng J
Oncol Lett; 2019 Jun; 17(6):5784-5792. PubMed ID: 31186805
[TBL] [Abstract][Full Text] [Related]
20. TYRO3: A potential therapeutic target in cancer.
Hsu PL; Jou J; Tsai SJ
Exp Biol Med (Maywood); 2019 Feb; 244(2):83-99. PubMed ID: 30714403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
